T0	KEYPHRASE-NOTYPES 0 12	Lyme disease,"","can"
T1	KEYPHRASE-NOTYPES 69 78	incidence,"ing","in "
T2	KEYPHRASE-NOTYPES 82 88	Canada," in","it "
T3	KEYPHRASE-NOTYPES 119 129	high index,"n a","of "
T4	KEYPHRASE-NOTYPES 133 142	suspicion," of"," La"
T5	KEYPHRASE-NOTYPES 144 164	Laboratory diagnosis,"on.","is "
T6	KEYPHRASE-NOTYPES 170 184	2-step process,"s a","5 I"
T7	KEYPHRASE-NOTYPES 195 199	case,"his"," th"
T8	KEYPHRASE-NOTYPES 205 224	emergency physician,"the","ord"
T9	KEYPHRASE-NOTYPES 237 252	screening ELISA,"the","(en"
T10	KEYPHRASE-NOTYPES 254 287	enzyme-linked immunosorbent assay,"SA "," fo"
T11	KEYPHRASE-NOTYPES 298 305	patient,"our"," If"
T12	KEYPHRASE-NOTYPES 314 326	ELISA result,"the","is "
T13	KEYPHRASE-NOTYPES 361 373	Western blot,"r a"," A "
T14	KEYPHRASE-NOTYPES 377 398	positive Western blot,". A","res"
T15	KEYPHRASE-NOTYPES 419 428	diagnosis,"the","5 L"
T16	KEYPHRASE-NOTYPES 431 443	Lyme disease,"s.5","sho"
T17	KEYPHRASE-NOTYPES 472 479	patient,"any","wit"
T18	KEYPHRASE-NOTYPES 487 496	new onset,"h a","of "
T19	KEYPHRASE-NOTYPES 500 510	Bell palsy," of"," Cu"
T20	KEYPHRASE-NOTYPES 512 545	Current treatment recommendations,"sy.","for"
T21	KEYPHRASE-NOTYPES 569 581	Lyme disease,"ted","wit"
T22	KEYPHRASE-NOTYPES 587 621	central nervous system involvement,"ith","inc"
T23	KEYPHRASE-NOTYPES 630 641	ceftriaxone,"ude","and"
T24	KEYPHRASE-NOTYPES 646 656	oxycycline,"and"," [6"
T25	KEYPHRASE-NOTYPES 671 678	patient,"his"," yo"
T26	KEYPHRASE-NOTYPES 692 704	Western blot,"r a"," ex"
T27	KEYPHRASE-NOTYPES 717 729	prescription,"his","of "
T28	KEYPHRASE-NOTYPES 733 744	doxycycline," of","to "
T29	KEYPHRASE-NOTYPES 759 777	full 21-day course,"e a"," ar"
T30	KEYPHRASE-NOTYPES 787 796	follow-up,"nge"," an"
T31	KEYPHRASE-NOTYPES 825 852	Lyme disease facial palsies,"ost","res"
